Date: Thursday, 14th May 2020
Time: 12noon to 1pm AEST
The effects of COVID-19 have been far reaching with negative impacts being felt globally. While most industries have suffered greatly, the medical industry is operating at two speeds. Quests for vaccines and treatments for COVID-19 are being fast tracked to clinical trials while other innovations have slowed or have been put on hold entirely.
This webinar focuses on insights into how the regenerative medicine sector is coping with the unprecedented impacts of the pandemic and what can be done now to prepare for a fast start in order to make up for lost time.
We have gathered thought leaders in this field from around the world to share their experiences and insights.
Dr Michael May, President and CEO, CCRM
Prof John Rasko AO, Head of Department, Cell & Molecular Therapies, Royal Prince Alfred Hospital
Mr Brent McPherson, (Logistician) National BD Manager, World Courier Ltd
Dr Panfeng Fang, VP/CTO, Eyecure Therapeutics